Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats

Journal of Psychopharmacology

Volumn 18, Issue 2, 2004, Pages 149-155

  Fell, M J ^a   Marshall, K M ^a   Williams, J ^a   Neill, Jo C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Food intake; Oestrous cycle; Olanzapine; Prolactin; Rat; Reproductive function; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; OLANZAPINE; PROLACTIN; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ESTRUS CYCLE; FEMALE; FEMALE GENITAL SYSTEM; FLUID INTAKE; FOOD INTAKE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; RAT STRAIN; REPRODUCTION; SEXUAL DYSFUNCTION; UTERUS WEIGHT; WEIGHT GAIN;

ABDOMEN; ADIPOSE TISSUE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY COMPOSITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRUG ADMINISTRATION SCHEDULE; EATING; ESTROUS CYCLE; FEMALE; INJECTIONS, INTRAPERITONEAL; ORGAN SIZE; PROLACTIN; RATS; REPRODUCTION; TIME FACTORS; UTERUS; WEIGHT GAIN;

EID: 3242740983     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881104042613     Document Type: Article

References (39)

1. Allison D B, Mentore J L, Heo M, Chandler L P, Cappelleri J C, Infante M C, Weiden P J (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 756: 1686-1696
2. Baptista T (1999) Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiat Scand 100: 3-16
3. Baptista T, Parada M, Hernandez L (1987) Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 27: 399-405
4. Baptista T, Contreras Q, Teneud L, Albornoz M A, Acosta A, Paez X, de Quijada M, LaCruz A, Hernandez L (1998) Mechanism of the neuroleptic-induced obesity in female rats. Prog Neuropsychopharmacol Biol Psychiatry 22: 187-198
5. Baptista T, Araujo de Baptista E, Ying Kin N M, Beaulieu S, Walker D, Joober R, Lalonde J, Richard D (2002) Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res 957: 144-151
6. Basson B R, Kinon B J, Taylor C C, Szymanski K A, Gilmore J A, Tollefson G D (2001) Factors influencing acute weight gain change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62: 231-238
7. Beasley, C M Jr, Hamilton S H, Crawford A M, Dellva M A, Tollefson G D, Tran P V, Blin O, Beuzen J N (1997) Olanzapine vs. haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol 7: 125-137
8. Benvenga M J (2002) Can clinical weight gain produced by atypical antipsychotic agents be modelled in the rat? Soc Neurosci Abstr 707: 4
9. Benvenga M J, Leander J D (1997) Increased food consumption by clozapine, but not by olanzapine, in satiated rats. Drug Develop Res 41: 48-50
10. Bobes J, Garc A P M P, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A (2003). Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29: 125-147
11. Casey D E and Zorn S H (2001) The pharmacology of weight gain with antipsychotics, J Clin Psychiatry 62: 4-10
12. Clifton P G, Rusk I N, Cooper S J (1991) Contrasting effects of D1 and D2 antagonists on food and water consumption in rats. Behav Neurosci 105: 472-481
13. Crawford A M, Beasley C M Jr, Tollefson G D (1997) The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 26: 41-54
14. Daniels A J, Grizzle M K, Strole C, Ignar D, Jones D N C (2003) Antipsychotic induced weight gain: effects of olanzapine and ziprasidone in female rats. J Psychopharmacol 17: A52
15. Dickson R A, Glazer W M (1999) Neuroleptic-induced hyperprolactinemia. Schizophr Res 35 (Suppl): S75
16. Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker W W (2001) Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry 158: 1719-1722
17. Esel E, Basturk M, Saffet Gonul A, Kula M, Tayfun Turan M, Yabanoglu I, Sofuoglu S (2001) Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients. Psychoneuroendocrinology 26: 641-647
18. Fox R R, Laird C W (1970) Sexual cycles. In Hafez E S E (ed.), Reproduction and breeding techniques for laboratory animals. Lea & Fibiger, Philadelphia
19. Ganguli R, Brar J S, Ayrton Z (2001) Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophr Res 49: 261-267
20. Goodnick P J, Rodriguez L, Santana O (2002) Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 3: 1381-1391
21. Goudie A J, Smith J A, Halford J C (2002) Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16: 291-296
22. Hartfield A W, Moore N A, Clifton P G (2003) Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology (Berl) 167: 115-122
23. Heiman M L, Leander J D, Breier A (2001) A preclinical study on the mechanisms underlying weight gain during olanzapine treatment. World J Biol Psychiatry 2: 215S
24. Kapur S, Zipursky R B, Remington G, Jones C, DaSilva J, Wilson A A, Houle S (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 755: 928-931
25. Kapur S, Remington G (2001) Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Ann Rev Med 52: 503-517
26. Kaur G, Kulkarni S K (2002) Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog Neuropsychopharmacol Biol Psychiatry 26: 277-285
27. Kinon B J, Basson B R, Gilmore J A, Tollefson G D (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 62: 92-100
28. Kinon B J, Gilmore J A, Liu H, Halbreich U M (2003) Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology 28 (Suppl 2): 69-82
29. Kroeze W K, Hufeisen S J, Popadak B A, Renock S M, Steinberg S, Ernsberger P, Jayathilake K, Meltzer H Y, Roth B L (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28: 519-526
30. Lee M D, Clifton P G (2002) Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol Biochem Behav 71: 147-154
31. Marshall K M, Kendall R, Reynolds G P, Neill J C (2002) The atypical antipsychotic risperidone disrupts the oestrous cycle and induces weight gain in female rats. J Psychopharmacol 16: A51
32. Meltzer H Y, McGurk S R (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25: 233-255
33. Nasrallah H (2003) A review of the effect of atypical antipsychotics on weight Psychoneuroendocrinology 28 (Suppl 1): 83-96
34. Neill J C, Fell M J, Reynolds G P, Marshall K M (2002) Effects of the classical antipsychotic haloperidol on weight gain, oestrous cycle and uterine weight in female rats. J Psychopharmacol 16: A50
35. Peuskens J (1997) Prolactin elevation and sexual dysfunction, In Peuskens J (ed.), A literature review of prolactin in schizophrenia. Clear Prospectives: Management Issues in Schizophrenia 1(3): 17-27
36. Pouzet B, Mow T, Kreilgard M, Velschow S (2003) Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in humans. Pharmacol Biochem Behav 75: 133-140
37. Terry P (1996) Dopamine receptor subtypes in ingestive behaviour. In Cooper S J, Clifton P G (eds), Drug receptor subtypes and ingestive behaviour. Academic Press, London
38. Thornton-Jones Z, Neill J C, Reynolds G P (2002) The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study, J Psychopharmacol 16: 35-37
39. Wetterling T (2001) Bodyweight gain with atypical antipsychotics. A comparative review. Drug Safety 24: 59-73